For Research Use Only. Not for human use.
AOD9604 is a modified analogue of the hGH C-terminal fragment (residues 177–191 with N-terminal tyrosine addition and disulfide cyclisation), first synthesized in the 1990s by Metabolic Pharmaceuticals. It has been studied for its selective stimulation of lipolysis via beta-3 adrenergic receptor upregulation in adipose tissue without elevating IGF-1 or producing hGH-like anabolic side effects. This research-grade lyophilized powder is synthesized under strict quality controls and includes full analytical documentation, making it suitable for metabolic, lipolytic, and cartilage repair research applications.
Key Scientific Features
- High-purity AOD9604 (≥ 98% by HPLC/MS, cyclized acetate salt form)
- Verified 16-amino-acid sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (disulfide bridge between Cys7–Cys14)
- Lyophilized formulation for enhanced long-term stability
- Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis
- Manufactured in GMP-aligned, ISO-compliant facilities
- Suitable for lipolytic assays, beta-3 AR modulation studies, and osteoarthritis research
Research-Referenced Attributes (Based on scientific literature; not intended as therapeutic claims.)
- Stimulates lipolysis and fat oxidation via beta-3 adrenergic receptor upregulation in adipose tissue in preclinical models
- Modulates lipid profiles in obese rodent models without IGF-1 elevation
- Investigated for cartilage repair and osteoblast stimulation in preclinical research settings
- No genotoxic, mutagenic, or diabetogenic effects observed in preclinical safety studies
- Studied in metabolic syndrome and NAFLD preclinical research models
Why Researchers Choose Nationwide Peptides AOD9604
- Exact clinical-sequence match with tyrosine addition and disulfide cyclization
- Consistent potency and batch-to-batch reproducibility
- Transparent analytical data (HPLC >98%, MS confirmation)
- Trusted by metabolic endocrinology, lipolysis, and orthopedics research laboratories
- Competitive research pricing with bulk options
